 | • レポートコード：MRC2302D131 • 出版社/出版日：Transparency Market Research / 2022年12月21日 • レポート形態：英語、PDF、185ページ • 納品方法：Eメール（受注後24時間以内） • 産業分類：医療 |
| Single User | ￥811,300 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,231,300 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,651,300 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、2022年に444.7百万ドルであった世界の迷走神経刺激装置市場規模が2031年には11億ドルとなり、予測期間の間に年平均10.1％増加すると展望しています。本資料では、迷走神経刺激装置の世界市場について徹底調査し、序論、仮定・調査方法、エグゼクティブサマリー、市場概要、主要インサイト、製品別（埋め込み型、非侵襲型（tVNS））分析 、生体材料別（セラミック、金属、高分子）分析、用途別（疼痛管理、てんかん発作、うつ病・不安、肥満管理、その他）分析、エンドユーザー別（病院、外来手術センター（ASC）、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、中南米）分析、競争状況などを掲載しています。本資料は、ReShape Lifesciences, Inc.、LivaNova LLC、electroCore, Inc.、MicroTransponder Inc.、Parasym Ltd.、Cerebral Inc.、Cerbomed GmbH、Neuvana, LLC、Nevro Corp.、NeuroPace Inc.などの企業情報を収録しています。 ・序論 ・仮定・調査方法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界の迷走神経刺激装置市場規模：製品別 - 埋め込み型迷走神経刺激装置の市場規模 - 非侵襲型（tVNS）迷走神経刺激装置の市場規模 ・世界の迷走神経刺激装置市場規模：生体材料別 - セラミック材料迷走神経刺激装置の市場規模 - 金属材料迷走神経刺激装置の市場規模 - 高分子材料迷走神経刺激装置の市場規模 ・世界の迷走神経刺激装置市場規模：用途別 - 疼痛管理における市場規模 - てんかん発作における市場規模 - うつ病・不安における市場規模 - その他における市場規模 ・世界の迷走神経刺激装置市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センター（ASC）における市場規模 - その他における市場規模 ・世界の迷走神経刺激装置市場規模：地域別 - 北米の迷走神経刺激装置市場規模 - ヨーロッパの迷走神経刺激装置市場規模 - アジア太平洋の迷走神経刺激装置市場規模 - 中東・アフリカの迷走神経刺激装置市場規模 - 中南米の迷走神経刺激装置市場規模 ・競争状況 |
Vagus Nerve Stimulator Market – Scope of Report
TMR’s report on the global vagus nerve stimulator market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global vagus nerve stimulator market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vagus nerve stimulator market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the vagus nerve stimulator market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global vagus nerve stimulator market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global vagus nerve stimulator market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global vagus nerve stimulator market.
The report delves into the competitive landscape of the global vagus nerve stimulator market. Key players operating in the global vagus nerve stimulator market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global vagus nerve stimulator market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market vagus nerve stimulator.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vagus Nerve Stimulator Market
4. Market Overview
4.1. Introduction
4.1.1. Segmentation Definition
4.1.2. Industry Evolution /Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vagus Nerve Stimulator Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/Globally
5.3. Pricing Analysis
5.4. COVID-19 Impact Analysis
6. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Implantable
6.3.2. Non-invasive (tVNS)
6.4. Market Attractiveness Analysis, By Product Type
7. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Biomaterial, 2017–2031
7.3.1. Ceramics
7.3.2. Metallic
7.3.3. Polymeric
7.4. Market Attractiveness Analysis, By Biomaterial
8. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Pain Management
8.3.2. Epileptic Seizures
8.3.3. Depression and Anxiety
8.3.4. Obesity Management
8.3.5. Others
8.4. Market Attractiveness Analysis, By Application
9. Global Vagus Nerve Stimulator Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers (ASCs)
9.3.3. Others
9.4. Market Attractiveness Analysis, By End-user
10. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Region
11. North America Vagus Nerve Stimulator Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Implantable
11.2.2. Non-invasive (tVNS)
11.3. Market Value Forecast, by Biomaterial, 2017–2031
11.3.1. Ceramics
11.3.2. Metallic
11.3.3. Polymeric
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Pain Management
11.4.2. Epileptic Seizures
11.4.3. Depression and Anxiety
11.4.4. Obesity Management
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers (ASCs)
11.5.3. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Biomaterial
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Vagus Nerve Stimulator Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Implantable
12.2.2. Non-invasive (tVNS)
12.3. Market Value Forecast, by Biomaterial, 2017–2031
12.3.1. Ceramics
12.3.2. Metallic
12.3.3. Polymeric
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Pain Management
12.4.2. Epileptic Seizures
12.4.3. Depression and Anxiety
12.4.4. Obesity Management
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers (ASCs)
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Biomaterial
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Implantable
13.2.2. Non-invasive (tVNS)
13.3. Market Value Forecast, by Biomaterial, 2017–2031
13.3.1. Ceramics
13.3.2. Metallic
13.3.3. Polymeric
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Pain Management
13.4.2. Epileptic Seizures
13.4.3. Depression and Anxiety
13.4.4. Obesity Management
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers (ASCs)
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Biomaterial
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Vagus Nerve Stimulator Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Implantable
14.2.2. Non-invasive (tVNS)
14.3. Market Value Forecast, by Biomaterial, 2017–2031
14.3.1. Ceramics
14.3.2. Metallic
14.3.3. Polymeric
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Pain Management
14.4.2. Epileptic Seizures
14.4.3. Depression and Anxiety
14.4.4. Obesity Management
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers (ASCs)
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Biomaterial
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Implantable
15.2.2. Non-invasive (tVNS)
15.3. Market Value Forecast, by Biomaterial, 2017–2031
15.3.1. Ceramics
15.3.2. Metallic
15.3.3. Polymeric
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Pain Management
15.4.2. Epileptic Seizures
15.4.3. Depression and Anxiety
15.4.4. Obesity Management
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers (ASCs)
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Biomaterial
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company, 2021
16.3. Company Profiles
16.3.1. ReShape Lifesciences, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. LivaNova LLC
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. electroCore, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. MicroTransponder Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Parasym Ltd.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Cerebral Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Cerbomed GmbH
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. Neuvana, LLC
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview
16.3.9. Nevro Corp.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. NeuroPace Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview